The Era of PARP inhibitors in ovarian cancer: “Class Action” or not? A systematic review and meta-analysis

The Era of PARP inhibitors in ovarian cancer: “Class Action” or not? A systematic review and meta-analysis

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Critical Reviews in Oncology/Hematology - Volume 131, November 2018, Pages 83-89

Nicoletta Staropoli, Domenico Ciliberto, Teresa Del Giudice, Eleonora Iuliano, Maria Cucè, Francesco Grillone, Angela Salvino, Vito Barbieri, Antonio Russo, Pierfrancesco Tassone, Pierosandro Tagliaferri,